Sfoglia per AUTORE
VANNUCCHI AM
Collezione ASL Alessandria
Items : 2
JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy. in Journal of clinical medicine / J Clin Med. 2021 Aug 23;10(16):3752. doi: 10.3390/jcm10163752.
2021
AO Cuneo
ASL Alessandria
AOU San Luigi di Orbassano
AO Cuneo
ASL Alessandria
AOU San Luigi di Orbassano
Tedeschi A; Festuccia MB; Monforte AD; Capochiani E; Selleri C; Simonetti F; Saracino A; Rapezzi D; Badagliacca MR; Falasca K; Molteni A; Palazzolo R; Schettino G; Bocchia M; Turrini M; Ascierto PA; Paley C; Saglio G; Coco P; D'Alessio A; Zuurman M; Morelli M; Mortara A; Vannucchi AM;
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results. in Blood / Blood. 2017 Oct 12;130(15):1768-1771. doi: 10.1182/blood-2017-02-765032. Epub 2017 Aug 21.
2017
ASL Alessandria
ASL Alessandria
Verstovsek S; Passamonti F; Rambaldi A; Barosi G; Rumi E; Gattoni E; Pieri L; Zhen H; Granier M; Assad A; Cazzola M; Kantarjian HM; Barbui T; Vannucchi AM;